Last $1,073 MXN
Change Today 0.00 / 0.00%
Volume 0.0
DD* On Other Exchanges
New York
EN Paris
As of 4:08 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

du pont (e.i.) de nemours (DD*) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/19/14 - $1,073
52 Week Low
01/28/14 - $786.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DU PONT (E.I.) DE NEMOURS (DD*)

du pont (e.i.) de nemours (DD*) Related Businessweek News

View More BusinessWeek News

du pont (e.i.) de nemours (DD*) Details

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides. The company’s Electronics and Communications segment supplies materials and systems, including photopolymers and electronic materials for photovoltaic products, consumer electronics, displays, and advanced printing. The Industrial Biosciences segment develops and manufactures a portfolio of enzymes. The Nutrition and Health segment offers cultures, emulsifiers, gums, natural sweeteners, and soy-based food ingredients. The Performance Chemicals segment offers industrial and specialty chemical products for markets, including plastics and coatings, textiles, mining, pulp and paper, water treatment, and healthcare; titanium dioxide products; and industrial and specialty fluorochemicals, fluoropolymers, and performance chemicals. The Performance Materials segment provides thermoplastic and thermoset engineering polymers, elastomers, films, parts, and systems and solutions for the automotive original equipment manufacturers and associated after-market industries, as well as electrical, electronics, packaging, construction, oil, photovoltaics, aerospace, chemical processing, and consumer durable goods. The Safety and Protection segment primarily offers nonwovens, aramids, and solid surfaces for the construction, transportation, communications, industrial chemicals, oil and gas, electric utilities, automotive, manufacturing, defense, homeland security, and safety consulting industries. The Pharmaceuticals segment represents its interest in the collaboration relating to Cozaar/Hyzaar antihypertensive drugs. The company was founded in 1802 and is headquartered in Wilmington, Delaware.

64,000 Employees
Last Reported Date: 02/5/14
Founded in 1802

du pont (e.i.) de nemours (DD*) Top Compensated Officers

Chairwoman and Chief Executive Officer
Total Annual Compensation: $1.4M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $716.3K
Executive Vice President
Total Annual Compensation: $696.3K
Executive Vice President
Total Annual Compensation: $695.8K
Compensation as of Fiscal Year 2013.

du pont (e.i.) de nemours (DD*) Key Developments

DuPont Nominates Board Members

DuPont announced that Trian to nominate four candidates for election to the company's board at the 2015 annual meeting, including Trian CEO, Nelson, Peltz and Robert Zatta, acting CEO of Rockwood.

Tennessee Valley Authority and DuPont Continues Partnership to Generate Power and Steam at TVA's Johnsonville Site in Humphreys County

The Tennessee Valley Authority and DuPont announced the continuation of a partnership to generate power and steam at TVA's Johnsonville site in Humphreys County, Tenn. The two companies, which have shared an arrangement in the county for nearly 20 years, recently agreed on a plan to convert an existing, limited-use combustio n turbine at Johnsonville into a highly efficient combined heat and power, or CHP, plant. The turbine will produce electricity for TVA customers and steam for DuPont.

Monsanto and DuPont Drop Patent Lawsuits against Each Other

Monsanto Co. and DuPont Co. have reached a settlement over patent infringement lawsuits that will end, for now anyway, a years-long battle which saw dueling litigation between the two seed sellers. The companies announced December 23, 2014, that they had settled and agreed to dismiss their patent infringement lawsuits against each other in U.S. District Court in St. Louis. Upon dismissal, Monsanto and DuPont will have no other litigation pending against each other. Monsanto's lawsuit against DuPont alleged that the latter had infringed on Monsanto's seed chipping technology. That technology allows Monsanto to extract small pieces of seeds for genetic analysis without killing the seed embryo. The innovation sped up the pace of research for Monsanto by allowing scientists to perform analysis without having to wait through a plant's life cycle to take genetic samples from the plant itself. DuPont's suit accused Monsanto of infringing on Dupont patents related to seed processing. The companies said in a statement that the agreement will allow the two companies to focus on new solutions for farmers. Terms of the settlement were not disclosed.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DD*:MM $1,072.85 MXN 0.00

DD* Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Honeywell International Inc $100.90 USD -0.99
LyondellBasell Industries NV $78.67 USD -0.60
Monsanto Co $118.62 USD -0.49
Reckitt Benckiser Group PLC 5,515 GBp +15.00
Dow Chemical Co/The $44.17 USD -0.39
View Industry Companies

Industry Analysis


Industry Average

Valuation DD* Industry Range
Price/Earnings 22.1x
Price/Sales 1.9x
Price/Book 4.3x
Price/Cash Flow 21.5x
TEV/Sales 1.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DU PONT (E.I.) DE NEMOURS, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at